Oruka Therapeutics, Inc. $ORKA
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-30
RECRUITING2
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| EVERLAST-A NCT07090330 |
P2 | Active, not recruiting | Plaque Psoriasis | 80 | 2026-03-25 (-5 mo) |
| EVERLAST-B NCT07290569 |
P2 | Active, not recruiting | Plaque Psoriasis | 160 | 2026-10-21 |
| ORKA-002 NCT07474792 |
P2 | Active, not recruiting | Plaque Psoriasis | 160 | 2027-10 |
| ORKA-002 NCT07783542 |
P2 | Recruiting | Hidradenitis Suppurativa (HS) | 200 | 2028-10 |
| ORKA-002-213 NCT07933783 |
P2 | Enrolling by invitation | Plaque Psoriasis | 160 | 2029-07-01 |
| ORKA-001 NCT07449702 |
P2 | Recruiting | Plaque Psoriasis | 240 | 2030-05 |